{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:54:55Z","timestamp":1753890895032,"version":"3.41.2"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T00:00:00Z","timestamp":1661817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p>17a-Hydroxylase\/17,20-lyase deficiency (17OHD) is caused by pathogenic mutations in <jats:italic>CYP17A1<\/jats:italic>. Female patients present with hypertension, hypokalemia, and sexual infantilism while males present with sex development disorder. Moyamoya disease (MMD) is a chronic cerebrovascular disease that frequently results in intracranial ischemia or hemorrhage. The present study describes a case of 17OHD and MMD in a 27-year-old phenotypically female (46, XY) patient and discusses the clinical features and characteristics of her genetic defect. Clinical, hormonal, radiological, and genetic analyses were performed and blood samples were collected for whole-exome sequencing (WES). The results of the WES revealed a homozygous intronic mutation (c.297+2T&amp;gt;C) in <jats:italic>CYP17A1<\/jats:italic>, which led to combined 17a-hydroxylase\/17,20-lyase deficiency, as well as novel variants in <jats:italic>PCNT<\/jats:italic> and <jats:italic>CNOT3<\/jats:italic> that might lead to MMD. To our knowledge, this study is the first to describe 17OHD accompanied by MMD. While several cases have previously described patients with 17OHD with histories of cerebral hemorrhage or cerebral ischemia, a correlation in genetic levels between 17OHD and MMD was not found. The risk of cerebrovascular accidents should be considered in patients with 17OHD and hypertension. Cerebrovascular examination in patients with 17OHD may be beneficial for the prevention of life-threatening intracranial vascular disease.<\/jats:p>","DOI":"10.3389\/fgene.2022.845016","type":"journal-article","created":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T05:34:46Z","timestamp":1661837686000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical and Genetic Analysis of a Patient With Coexisting 17a-Hydroxylase\/17,20-Lyase Deficiency and Moyamoya Disease"],"prefix":"10.3389","volume":"13","author":[{"given":"Jiaming","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danli","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenzhao","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangping","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/s0889-8529(08)70021-5","article-title":"The genetics, pathophysiology, and management of human deficiencies of P450c17","volume":"30","author":"Auchus","year":"2001","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"B2","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1136\/jnnp.2007.130666","article-title":"Novel epidemiological features of moyamoya disease","volume":"79","author":"Baba","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B3","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1159\/000442298","article-title":"Research progresses in understanding the pathophysiology of moyamoya disease","volume":"41","author":"Bersano","year":"2016","journal-title":"Cerebrovasc. Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1002\/ajmg.a.33252","article-title":"Majewski osteodysplastic primordial dwarfism type II (MOPD II): expanding the vascular phenotype","author":"Bober","year":"2010","journal-title":"Am. J. Med. Genet. A"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1016\/j.cub.2014.08.029","article-title":"A unique set of centrosome proteins requires pericentrin for spindle-pole localization and spindle orientation","volume":"24","author":"Chen","year":"2014","journal-title":"Curr. Biol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1073\/pnas.84.2.407","article-title":"Cytochrome P450c17 (steroid 17 alpha-hydroxylase\/17, 20 lyase): cloning of human adrenal and testis cDNAs indicates the same gene is expressed in both tissues","volume":"84","author":"Chung","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12881-016-0286-2","article-title":"Targeted next-generation sequencing identification of mutations in patients with disorders of sex development","volume":"17","author":"Dong","year":"2016","journal-title":"BMC Med. Genet."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1016\/S0140-6736(17)31431-9","article-title":"Congenital adrenal hyperplasia","volume":"390","author":"El-Maouche","year":"2017","journal-title":"Lancet"},{"key":"B9","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/00125817-200205000-00002","article-title":"Cardiovascular disease in neurofibromatosis 1: report of the NF1 cardiovascular task force","volume":"4","author":"Friedman","year":"2002","journal-title":"Genet. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"S61","DOI":"10.1046\/j.1440-1789.2000.00300.x","article-title":"Moyamoya disease","volume":"20","author":"Fukui","year":"2000","journal-title":"Neuropathology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.12007\/j.issn.0258\u20104646.2019.12.017","article-title":"Congenital adrenal hyperplasia with 17\u03b1 -hydroxylase deficiency: a case report","volume":"48","author":"Gao","year":"2019","journal-title":"J. China Med. Univ."},{"key":"B12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ajhg.2016.11.008","article-title":"Loss-of-Function mutations in YY1AP1 lead to grange syndrome and a fibromuscular dysplasia-like vascular disease","volume":"100","author":"Guo","year":"2017","journal-title":"Am. J. Hum. Genet."},{"key":"B13","doi-asserted-by":"publisher","first-page":"876","DOI":"10.3346\/jkms.2003.18.6.876","article-title":"Associations of Moyamoya patients with HLA class I and class II alleles in the Korean population","volume":"18","author":"Han","year":"2003","journal-title":"J. Korean Med. Sci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.ajhg.2014.01.018","article-title":"Loss of \u03b11\u03b21 soluble guanylate cyclase, the major nitric oxide receptor, leads to moyamoya and achalasia.","volume":"94","author":"Herve","year":"2014","journal-title":"Am. J. Hum. Genet."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e25492","DOI":"10.1371\/journal.pone.0025492","article-title":"CYP17A1 intron mutation causing cryptic splicing in 17\u03b1-hydroxylase deficiency","volume":"6","author":"Hwang","year":"2011","journal-title":"PLoS One"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"B17","doi-asserted-by":"publisher","first-page":"592","DOI":"10.16439\/j.cnki.1673-7245.2020.06.029","article-title":"17a-hydroxylase deficiency: a case report and literature review","volume":"28","author":"Li","year":"2020","journal-title":"Chin. J. Hypertens."},{"key":"B18","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/nature08494","article-title":"Finding the missing heritability of complex diseases","volume":"461","author":"Manolio","year":"2009","journal-title":"Nature"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.clineuro.2009.11.009","article-title":"Epidemiological and clinical features of Moyamoya disease in Nanjing, China","volume":"112","author":"Miao","year":"2010","journal-title":"Clin. Neurol. Neurosurg."},{"key":"B21","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1507\/endocrj1954.30.763","article-title":"A case of 17 alpha-hydroxylase deficiency with special reference to the renal kallikrein-kinin system","volume":"30","author":"Mita","year":"1983","journal-title":"Endocrinol. Jpn."},{"key":"B22","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1089\/dna.1987.6.439","article-title":"Cloning and sequence of the human gene for P450c17 (steroid 17 alpha-hydroxylase\/17, 20 lyase): similarity with the gene for P450c21","volume":"6","author":"Picado-Leonard","year":"1987","journal-title":"DNA"},{"key":"B23","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41436-019-0639-2","article-title":"The pleiotropy associated with de novo variants in CHD4, CNOT3, and SETD5 extends to moyamoya angiopathy","volume":"22","author":"Pinard","year":"2020","journal-title":"Genet. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s10038-004-0143-6","article-title":"A novel susceptibility locus for moyamoya disease on chromosome 8q23","volume":"49","author":"Sakurai","year":"2004","journal-title":"J. Hum. Genet."},{"key":"B26","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1093\/bioinformatics\/btr667","article-title":"Integrated annotation and analysis of genetic variants from next-generation sequencing studies with variant tools","volume":"28","author":"San Lucas","year":"2012","journal-title":"Bioinformatics"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1056\/NEJMra0804622","article-title":"Moyamoya disease and moyamoya syndrome","volume":"360","author":"Scott","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1089\/dna.1991.10.359","article-title":"Regional mapping of genes encoding human steroidogenic enzymes: P450scc to 15q23-q24, adrenodoxin to 11q22; adrenodoxin reductase to 17q24-q25; and P450c17 to 10q24-q25","volume":"10","author":"Sparkes","year":"1991","journal-title":"DNA Cell Biol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/archneur.1969.00480090076012","article-title":"Cerebrovascular \"moyamoya\" disease.Disease showing abnormal net-like vessels in base of brain","volume":"20","author":"Suzuki","year":"1969","journal-title":"Arch. Neurol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/02688697.2019.1672859","article-title":"Moyamoya syndrome in a male pseudohermaphrodite patient with congenital adrenal hyperplasia - a rare association. Case report and review of literature","author":"Vasudevan","year":"2019","journal-title":"Br. J. Neurosurg."},{"key":"B31","first-page":"437","article-title":"11\u03b2-hydroxylase deficiency combined with Moyamoya disease and true precocious puberty","author":"Wang","year":"2001"},{"key":"B32","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2176\/nmc.52.245","article-title":"Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis)","volume":"52","author":"Willis","year":"2012","journal-title":"Neurol. Med. Chir."},{"key":"B33","first-page":"1515","article-title":"Deficiency of 17a-hydroxylase\/17, 20-carbon chain lyase in 11 cases","volume":"25","author":"Yu","year":"2010","journal-title":"Clin. meta-analysis"},{"key":"B34","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.beem.2015.04.010","article-title":"Inherited forms of mineralocorticoid hypertension","volume":"29","author":"Zennaro","year":"2015","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.12998\/wjcc.v9.i8.1923","article-title":"17\u03b1-hydroxylase\/17, 20 carbon chain lyase deficiency caused by p.Tyr329fs homozygous mutation: Three case reports","volume":"9","author":"Zhang","year":"2021","journal-title":"World J. Clin. Cases"}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2022.845016\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T05:34:51Z","timestamp":1661837691000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2022.845016\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,30]]},"references-count":35,"alternative-id":["10.3389\/fgene.2022.845016"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2022.845016","relation":{},"ISSN":["1664-8021"],"issn-type":[{"type":"electronic","value":"1664-8021"}],"subject":[],"published":{"date-parts":[[2022,8,30]]},"article-number":"845016"}}